EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Elevated Serum Soluble Syndecan-1 Is Associated with Lupus Nephritis Flares: A Cross-Sectional Study

Nicte Selene Fajardo-Robledo iD, Heriberto Jacobo-Cuevas, Juan Manuel Ponce-Guarneros iD, Soraya Amalí Zavaleta-Muñiz, Erika Anita Aguilar-Chavez, Alberto Daniel Rocha-Muñoz, Edy David Rubio-Arellano iD, Juan Manuel Viveros-Paredes iD, Eva Maria Olivas-Flores iD, Felipe Alexis Avalos-Salgado iD, Aniel Jessica Leticia Brambila-Tapia iD, Fabiola Gonzalez-Ponce iD und 4 weitere

International Journal of Molecular Sciences · 26.04.2026 · 27 (9) · 3851

DOI: 10.3390/ijms27093851 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.04.2026. Verfasst von Nicte Selene Fajardo-Robledo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Investigación y Desarrollo Farmacéutico, Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Univ…. Hauptthemen laut MEDLINE: Syndecan-1, Lupus Nephritis. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis (LN) is a severe immune-mediated renal disorder causing significant morbidity and mortality in patients with systemic lupus erythematosus (SLE). Traditional biomarkers (serum complement components C3 and C4 and anti-dsDNA antibodies) have limited sensitivity and specificity for detecting renal flares; thus, new markers are needed to improve relapse detection and therapeutic response monitoring. We conducted a cross-sectional study including 71 women with SLE and 20 age- and sex-matched controls. Clinical data were collected, global activity was evaluated using the SLEDAI, and renal activity was evaluated using the renal SLEDAI (rSLEDAI). Serum syndecan-1 (SDC-1) and anti-dsDNA were measured using ELISA, and 24 h proteinuria was quantified. According to the rSLEDAI, 38 patients (53.5%) had LN flare, with a mean SDC-1 level of 108.5 ± 69.3 ng/mL and anti-dsDNA level of 113.1 ± 148.8 IU/mL. SDC-1 was correlated with the rSLEDAI (r = 0.32; p = 0.006), prednisone dose (r = 0.37; p = 0.002), proteinuria (r = 0.33; p = 0.005), and anti-dsDNA (r = 0.33; p = 0.006), while anti-dsDNA was positively correlated with proteinuria (r = 0.39; p = 0.001 and SDC-1 (r = 0.33; p = 0.006) and negatively correlated with age (r = −0.33; p = 0.006). High SDC-1 (cutoff ≥ 89 ng/mL) had higher sensitivity for detecting renal flares than anti-dsDNA (66% vs. 45%). In the multivariable analysis, high SDC-1 levels had around a 3-fold higher risk of being associated with LN flares, independently of anti-dsDNA and complement component levels. These results support serum SDC-1 as a promising biomarker for identifying renal flares in SLE patients, and it should be combined with traditional biomarkers to increase its value as a clinical tool. Follow-up studies are required to determine its value for predicting long-term renal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Syndecan-1Lupus NephritisHumansFemaleCross-Sectional StudiesBiomarkersAdultProteinuriaAntibodies, AntinuclearMiddle Aged

Stichwörter der Autor:innen

anti-dsDNAlupus nephritisproteinuriasensitivityspecificitysyndecan-1

Substanzen

Syndecan-1BiomarkersSDC1 protein, humanAntibodies, Antinuclear

Autor:innen und Institutionen

  • Laboratorio de Investigación y Desarrollo Farmacéutico, Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.
  • Cuerpo Académico UDG-CA-1061 "Farmacología Traslacional", Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico.
  • Group for the Assessment of Prognosis Biomarkers in Autoimmune Disorders, Centro Universitario de Ciencias de la Salud, Guadalajara 44340, Jalisco, Mexico.
  • Programa de Postdoctorado en el Departamento de Psicología Básica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
  • Programa de Doctorado en Farmacología, Departamento de Fisiología, Instituto de Terapéutica Experimental y Clínica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, M…
  • Cuerpo Académico UDG-CA-1172 "Alteraciones Inmunologicas y Enfermedades Cronico-Degenerativas", Centro Universitario de Ciencias de la Salud, Guadalajara 44340, Jalisco, Mexico.

ORCID-Profile: Nicte Selene Fajardo-Robledo, Juan Manuel Ponce-Guarneros, Edy David Rubio-Arellano, Juan Manuel Viveros-Paredes, Eva Maria Olivas-Flores, Felipe Alexis Avalos-Salgado, Aniel Jessica Leticia Brambila-Tapia, Fabiola Gonzalez-Ponce, Ernesto German Cardona-Muñoz, Laura Gonzalez-Lopez, Jorge Ivan Gamez-Nava

Zitieren

APA

Fajardo-Robledo, N. S., Jacobo-Cuevas, H., Ponce-Guarneros, J. M., Zavaleta-Muñiz, S. A., Aguilar-Chavez, E. A., Rocha-Muñoz, A. D., Rubio-Arellano, E. D., Viveros-Paredes, J. M., Olivas-Flores, E. M., Avalos-Salgado, F. A., Brambila-Tapia, A. J. L., Gonzalez-Ponce, F., Cardona-Muñoz, E. G., Gonzalez-Lopez, L., Gamez-Nava, J. I., & Group for the Assessment of Prognosis Biomarkers in Autoimmune Disorders (2026). Elevated Serum Soluble Syndecan-1 Is Associated with Lupus Nephritis Flares: A Cross-Sectional Study. International Journal of Molecular Sciences, 27(9), 3851. https://doi.org/10.3390/ijms27093851

Vancouver

Fajardo-Robledo NS, Jacobo-Cuevas H, Ponce-Guarneros JM, Zavaleta-Muñiz SA, Aguilar-Chavez EA, Rocha-Muñoz AD, et al. Elevated Serum Soluble Syndecan-1 Is Associated with Lupus Nephritis Flares: A Cross-Sectional Study. International Journal of Molecular Sciences. 2026;27(9):3851. doi:10.3390/ijms27093851

BibTeX
@article{FajardoRobledo2026,
  author = {Fajardo-Robledo, Nicte Selene and Jacobo-Cuevas, Heriberto and Ponce-Guarneros, Juan Manuel and Zavaleta-Muñiz, Soraya Amalí and Aguilar-Chavez, Erika Anita and Rocha-Muñoz, Alberto Daniel and Rubio-Arellano, Edy David and Viveros-Paredes, Juan Manuel and Olivas-Flores, Eva Maria and Avalos-Salgado, Felipe Alexis and Brambila-Tapia, Aniel Jessica Leticia and Gonzalez-Ponce, Fabiola and Cardona-Muñoz, Ernesto German and Gonzalez-Lopez, Laura and Gamez-Nava, Jorge Ivan and Group for the Assessment of Prognosis Biomarkers in Autoimmune Disorders, Group for the Assessment of Prognosis Biomarkers in Autoimmune Disorders},
  title = {Elevated Serum Soluble Syndecan-1 Is Associated with Lupus Nephritis Flares: A Cross-Sectional Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {3851},
  doi = {10.3390/ijms27093851}
}
Kostenlos starten →